Coherus Oncology, Inc. short interest in 2024
In 2024, Coherus Oncology, Inc.'s disclosed short interest ran from 24.63% of shares outstanding on 12 Jan 2024 to 26.66% on 31 Dec 2024, a change of +2.03 percentage points. The year's high was 28.68% on 15 Nov 2024 and its low 18.90% on 30 Apr 2024, averaging 22.72% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.65 days on 13 Sep 2024. Full history: Coherus Oncology, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 24.63% (12 Jan 2024)
- End of year
- 26.66% (31 Dec 2024)
- Change
- +2.03 pp
- High
- 28.68% (15 Nov 2024)
- Low
- 18.90% (30 Apr 2024)
- Average
- 22.72%
- Highest days to cover
- 24.65 (13 Sep 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 24.63% | 3.64 | results (8-K) |
| 31 Jan 2024 | 25.26% | 4.45 | |
| 15 Feb 2024 | 22.73% | 7.54 | |
| 29 Feb 2024 | 21.73% | 10.25 | |
| 15 Mar 2024 | 23.27% | 8.42 | results (8-K), 10-K filed |
| 28 Mar 2024 | 21.06% | 8.01 | |
| 15 Apr 2024 | 19.34% | 11.92 | |
| 30 Apr 2024 | 18.90% | 15.03 | |
| 15 May 2024 | 18.99% | 10.58 | 10-Q filed, results (8-K) |
| 31 May 2024 | 19.23% | 16.43 | |
| 14 Jun 2024 | 19.35% | 17.69 | |
| 28 Jun 2024 | 20.08% | 12.05 | |
| 15 Jul 2024 | 20.07% | 13.08 | |
| 31 Jul 2024 | 19.67% | 14.26 | |
| 15 Aug 2024 | 20.84% | 13.18 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 21.83% | 12.69 | |
| 13 Sep 2024 | 21.78% | 24.65 | |
| 30 Sep 2024 | 24.27% | 8.85 | |
| 15 Oct 2024 | 25.91% | 8.89 | |
| 31 Oct 2024 | 27.35% | 16.12 | |
| 15 Nov 2024 | 28.68% | 9.63 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 26.66% | 6.91 | |
| 13 Dec 2024 | 26.97% | 1.91 | |
| 31 Dec 2024 | 26.66% | 12.38 |
See also: Coherus Oncology, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.